This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Julianne Hull
CEO at WenStar Enterprizes

Profile

With 30 years’ experience in clinical development Julianne has successfully held global leadership roles in Vendor Management/Outsourcing, Clinical Data Management and Clinical Operations for several large and medium pharmaceutical companies (Pfizer, Wyeth, Marion Merrell Dow and Biogen). In these roles she has been an accomplished manager and motivator of staff based in China, India, Japan, Europe and US. Julianne received a DIA award for service to the pharmaceutical industry. Julianne is also an honorary life member of the ACDM.

Julianne is currently CEO of WenStar Enterprises a company she formed in 2011 to provide training and consultancy to the pharmaceutical industry.  WenStar Enterprises won a Southern Enterprise Award for Patient Safety earned for training during the COVID-19 epidemic

Agenda Sessions

  • LIVE Panel, Q&A and Audience Interaction: Juggling Regulatory Challenges for Clinical Trials in the Covid-19 era – Can we make it work?

    12:45
  • LIVE Panel, Q&A and Audience Interaction: Juggling Regulatory challenges for Clinical Trials in the Covid-19 era – Can we make it work?

    12:45
  • Change in the time of COVID-19

    10:05
  • LIVE PLENARY Panel, Q&A and Audience Interaction: The future of clinical trials

    14:35